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Abstract
Reactive oxygen species have been implicated in cellular injury during ischemia/reperfusion (I/R). Mitochondria are one of
the main targets of oxygen free radicals and damage to this organelle leads to cell death. Reports suggest that nitric oxide
(NO) may offer protection from damage during I/R. This study has looked at the functional changes and lipid alteration to
mitochondria during intestinal I/R and the protection offered by NO. It was observed that I/R of the intestine is associated
with functional alterations in the mitochondria as suggested by MTT reduction, respiratory control ratio and mitochondrial
swelling. Mitochondrial lipid changes suggestive of activation of phospholipase A2 and phospholipase D were also seen after
(I/R) mediated injury. These changes were prevented by the simultaneous presence of a NO donor in the lumen of the
intestine. These studies have suggested that structural and functional alterations of mitochondria are prominent features of
I/R injury to the intestine which can be ameliorated by NO. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
A reduction in intestinal blood £ow results in char-
acteristic mucosal lesions. During reperfusion, intes-
tinal mucosa shows signi¢cant cascade of destructive
events [1,2]. Although reperfusion is essential in or-
der to prevent anoxic cell death, it may be associated
with additional severe cellular damage. It is well
known that development of ischemia/reperfusion
(I/R)-induced organ injury is closely associated with
free radical production [3,4]. The e⁄ciency of the
endogenous antioxidant defense mechanism is impor-
tant in protecting against reperfusion injury.
Oxygen free radicals are implicated in the patho-
genesis of intestinal I/R injury [4^6]. The hypoxan-
thine-xanthine oxidase (XO) system appears to be an
important source of reactive oxygen species (ROS)
[7]. ROS react with nucleic acids, proteins, carbohy-
drates, and lipids to produce damage to these bio-
logical molecules. In addition to their direct tissue-
damaging e¡ect, ROS trigger the accumulation and
activation of neutrophils [7,8]. Our earlier studies
with XO-de¢cient animals suggest that during I/R
injury to the intestine, the invading phagocytes,
rather than XO, form an important source of oxygen
radicals [9].
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Mitochondrial respiration is the major source of
ATP, which is indispensable for the maintenance of
cellular integrity and the performance of cellular
functions. Oxygen free radicals are also produced
endogenously as a by-product by the mitochondrial
electron transport systems and mitochondria have
their own radical scavenging system to neutralize
these radicals [10]. Alteration in the balance between
radical production and scavenging ability is thought
to lead to mitochondrial injury. Indeed, the energy
producing system is impaired by free radicals in I/R-
induced organ injury [11]. Recently, we have shown
that mitochondria can withstand short periods of
ischemia, whereas long duration ischemia or reperfu-
sion results in irreversible damage to mitochondrial
function [12]. Earlier we have shown that in vitro
exposure of isolated intestinal mitochondria to
ROS results in membrane phospholipid alteration,
speci¢cally a decrease in phosphatidylethanolamine
(PE) and an increase in phosphatidic acid (PA)
due to activation of a phospholipase D associated
with intestinal mitochondria. These alterations in
mitochondrial lipids may play a role in causing
the functional alteration seen in oxidative stress
[13].
The role that nitric oxide (NO) plays in cytotoxic
events is unclear. Many reports suggest that NO me-
diates tissue injury during the I/R event [14^16]. Yet,
other reports suggest that NO may have a protective
e¡ect during ischemia/reperfusion injury [17^19]. NO
appears to be a regulator of regional blood £ow dur-
ing reperfusion following extremity ischemia. De-
creased NO production may contribute to impaired
regional blood £ow and mortality [20]. NO donors
have been shown to reduce the rise in reperfusion-
induced intestinal mucosal permeability [21,22]. Re-
cently, Terada et al. have shown that NO decreases
lung injury following intestinal ischemia [23]. We
have also recently shown that oxygen free radicals
mediated intestinal mitochondrial phospholipase D
(PLD) activation is attenuated by nitric oxide [24].
Little is known about intestinal mitochondrial lipid
alterations due to oxidative stress, during I/R. Earlier
reports indicate that reperfusion injury is associated
with activation of mucosal phospholipase A2 (PLA2)
[25] and accumulation of lysophospholipids could be
involved in mucosal injury caused by small intestinal
ischemia [26]. However, the role of PLD in I/R injury
of the small intestine has not been investigated. The
present study was carried out to clarify whether and
to what extent phospholipases are involved in I/R
injury of the small intestine in vivo, speci¢cally look-
ing at changes in mitochondria.
2. Materials and methods
Various lipid standards, HEPES, BSA, succinate
(sodium salt), ADP, sodium nitroprusside (SNP),
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetra-
zolium bromide), dimethyl sulfoxide (DMSO), pen-
tobarbital, EDTA and EGTA were obtained from
Sigma. Microtiter plates were supplied by Sterlin,
Middlesex (UK). All other chemicals used were of
analytical grade.
2.1. Development of ischemia/reperfusion
Development of I/R was done as described [12].
Brie£y, overnight fasted rats were anesthetized with
sodium pentobarbitone (50 mg/kg b.wt.). The small
intestine was isolated after a midline abdominal in-
cision and cannulated at both ends using silastic tub-
ing. The luminal contents were removed by perfusion
with normal saline and the superior mesenteric artery
(SMA) was exposed retroperitoneally. To perform
ischemia, the root of the SMA was occluded for
di¡erent time periods namely, 30, 60 and 90 min
with a clamp and released for 5 min for reperfusion.
The isolated intestinal loop was returned to the ab-
dominal cavity and the abdominal wall was closed to
minimize dehydration of the gut segment during the
course of the experiment. Body temperature was
maintained at 37‡C with an overhead lamp. After
the corresponding time periods, the intestine was re-
moved and enterocytes were isolated [27].
In a second group of animals, the same protocol
was followed; however, the nitric oxide donor, so-
dium nitroprusside was dissolved in saline (1 mM
¢nal concentration). Saline at 37‡C containing the
solubilized NO donor was then perfused via a peri-
staltic pump (Vickers Medical Treonic IP4 pump,
Basingstoke, UK) into the proximal jejunal lumen
at a rate of 1 ml/min starting 5 min after saline
wash. The test group was preconditioned with SNP
solution for 15 min before being subjected to ische-
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mia and this was continued throughout the experi-
mental protocol.
Control rats were also anesthetized and the small
intestine was isolated after midline abdominal inci-
sion. The intestine was cannulated at both ends using
silastic tubing and the luminal contents were re-
moved by perfusion with normal saline. Saline per-
fusion was then done as for the test group, except
that the SMA was not clamped. Like the test group,
the controls were also preconditioned for 15 min
with SNP solution.
2.2. Preparation of mitochondria
Mitochondria were isolated from enterocytes as
described by Masola and Evered [27]. Isolated mito-
chondrial fraction was suspended in EGTA free me-
dium containing 250 mM sucrose and 5 mM
HEPES, pH 7.4, and stored in ice at a protein con-
centration of 8^10 mg/ml. Protein was measured us-
ing BSA as standard [28]. Purity of the preparation
was judged by the enrichment of the marker enzyme,
succinate dehydrogenase [29].
2.3. MTT reduction by enterocyte mitochondria
Mitochondrial function was assessed by MTT re-
duction using a microplate reader as described with
slight modi¢cation [12]. In a total volume of 150 Wl
in each well, mitochondrial suspension correspond-
ing to 40^100 Wg protein was taken, 6 Wl of 1.25 mM
MTT added and made up to the volume with 25 mM
phosphate-bu¡ered saline. MTT was dissolved in
PBS and ¢ltered to remove small amounts of insolu-
ble residue in some batches of MTT. Plates were
incubated at 37‡C for 20 min followed by addition
of 150 Wl of DMSO and mixed thoroughly to dis-
solve the formazan. The plates were read on a multi-
well scanning spectrophotometer (ELISA reader) us-
ing a test wavelength of 570 nm and reference
wavelength of 630 nm. The amount of MTT forma-
zan formed was calculated from the standard curve
prepared using authentic MTT formazan (20^100
WM). Since succinate is a mitochondrial respiratory
substrate, formation of MTT formazan in the pres-
ence and absence of 1 mM succinate (¢nal concen-
tration) was tested.
2.4. Measurement of oxygen uptake
Oxygen uptake was determined polarographically
using a Clark-type electrode in 2 ml of respiratory
medium (225 mM sucrose, 5 mM MgCl2, 10 mM
KH2PO4, 20 mM KCl, 10 mM Tris, and 5 mM
HEPES pH 7.4), containing 5 mM succinate. One
mg/ml of mitochondrial protein was used. Oxygen
uptake was stimulated with 0.3 mM ADP. Respira-
tory control ratio was determined as described by
Eastabrook [30].
2.5. Mitochondrial swelling
Mitochondrial swelling was determined by the de-
crease in absorbance at 540 nm as described [31].
2.6. Histologic studies
Full-thickness samples of the small intestinal tissue
were ¢xed in 10% formalin, embedded in paraplast
and 3^4-Wm sections cut. The sections were stained
with hematoxylin and eosin and observed under a
light microscope.
2.7. Ultrastructural studies
Full-thickness samples of the small intestine were
¢xed in 2^5% glutaraldehyde, post-¢xed in osmium
tetroxide, and embedded in araldite. Sections of 1 Wm
were cut, stained with Toluidine blue and used to
select appropriate area for ultrastructural study.
Ultrathin sections were cut on a Leica Ultracut
UCT ultramicrotome with a diamond knife (Dia-
tome, Switzerland), stained with uranyl acetate and
lead citrate, and examined with a Phillips EM201C
electron microscope (Eindhoven, The Netherlands).
2.8. Lipid analysis
Total lipids were extracted by Bligh and Dyer’s
method [32] Neutral lipids were separated on silica
gel G plates using the solvent system hexane^diethyl
ether^acetic acid (80:20:1, v/v). Spots were identi¢ed
by iodine exposure, scraped and eluted. Cholesterol
[33], diglycerides and triglycerides [34] were estimated
as described. Free fatty acids were methylated and
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quantitated by gas chromatography after separation
on a 5% EGSS-X column. Individual phospholipids
were separated on silica gel H plates using the sol-
vent system chloroform^methanol^acetic acid^water
(25:15:4:2 v/v) [35] and quantitated by phosphate
estimation after acid hydrolysis [36]. For PA quanti-
tation, extracted lipids were spotted on silica gel G
plates impregnated with 0.5 M oxalic acid and sepa-
rated using the solvent system chloroform^metha-
nol^Con. HCl (85:134:0.5 v/v) [37]. PA spot corre-
sponding to standard was identi¢ed by iodine
exposure, scraped, eluted and quantitated by phos-
phate estimation after acid digestion. Our earlier
studies using intestinal mitochondrial PLD have
shown that this enzyme does not catalyze transphos-
phatidylation in the presence of alcohol [13,38], like
the recently reported yeast PLD [39,40].
2.9. Statistical analysis
Data are expressed as mean þ S.D. from three sep-
arate experiments. Statistical analysis was performed
with Student’s t-test to compare the changes.
3. Results
3.1. E¡ect of nitric oxide donor on morphological
changes triggered by ischemia/reperfusion
Control mucosa with and without nitric oxide per-
fusion showed normal crypts and villi (Fig. 1A1,B1,).
Blood vessels were also normal. With ischemia, there
was detachment of the villus epithelium leaving de-
nuded villi (Fig. 1A2) whereas luminal perfusion with
1 mM nitric oxide donor, SNP, showed greater pres-
ervation of villus epithelium (Fig. 1B2). The lamina
propria showed marked vascular dilatation, conges-
tion and hemorrhage both with and without nitric
oxide perfusion. Submucosal vessels showed dilata-
tion and congestion. In ischemia followed by reper-
fusion, villi appeared collapsed, shortened and
broadened and there was further detachment of vil-
lus epithelium (Fig. 1A3) whereas luminal perfusion
of SNP showed preservation of villus epithelium
(Fig. 1B3). I/R showed focal necrosis in crypt bases
that was not seen in the tissue exposed to nitric oxide
donor.
3.2. E¡ect of nitric oxide donor on ultrastructural
changes during ischemia/reperfusion
Control mucosa with and without nitric oxide per-
fusion showed normal crypts and villi. There were no
remarkable changes seen in mitochondria (Fig. 2a).
With ischemia, the villus epithelium showed detach-
ment. There was peripheral condensation of nuclear
chromatin and the mitochondria were markedly di-
lated with lucency of the matrix and disruption of
cristae. Endoplasmic reticulum was also dilated.
Crypts in the mucosa showed focal dilatation of mi-
tochondria with matrix lucency and disrupted cristae
as described in the villi (Fig. 2b). In ischemia fol-
lowed by short duration of reperfusion, villus epithe-
lial cells showed changes similar to those with ische-
mia alone. The crypt cells also showed focal
mitochondrial dilatation. Luminal perfusion with ni-
tric oxide donor, SNP, prevented the remarkable
changes that were seen in the ischemic mitochondria.
The microvilli and intercellular junctions were rela-
tively well preserved. Crypts of tissue exposed to ni-
tric oxide did not show mitochondrial dilatation or
Table 1
Neutral lipid content of isolated mitochondria from control, ischemia and ischemia followed by reperfusion
Neutral lipids Control I30 I60 I90 I30R I60R
Free fatty acids 111.90 þ 7.50 116.20 þ 3.90 120.36 þ 6.46 154.00 þ 8.2a 132.64 þ 7.2a 148.20 þ 7.3a
Cholesterol 86.89 þ 4.89 84.87 þ 5.90 87.14 þ 5.20 85.95 þ 5.10 85.79 þ 7.12 87.42 þ 7.60
Cholesteryl ester 30.74 þ 3.00 31.70 þ 2.70 32.27 þ 1.92 28.10 þ 2.50 30.37 þ 3.40 30.62 þ 1.37
Triglycerides 86.96 þ 5.00 86.03 þ 3.97 88.78 þ 6.36 90.35 þ 5.34 86.41 þ 5.85 86.43 þ 6.29
Diglycerides 54.43 þ 2.73 57.48 þ 2.20 58.18 þ 4.50 57.85 þ 3.48 58.92 þ 3.20 60.70 þ 2.88
Each value (nmol/mg protein) represents mean þ S.D. of three separate estimations. I30, 30-min ischemia alone; I60, 60-min ischemia
alone; I90, 90-min ischemia alone; I30R, 30-min ischemia followed by 5-min reperfusion; I60R, 60-min ischemia followed by by 5-min
reperfusion.
aP6 0.05 as compared to control mitochondria.
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Fig. 1. Light microscopic appearance of intestinal mucosa after ischemia and I/R and the e¡ect of NO on these alterations. (A1) Small
intestine of control rat with normal crypts and villi. (A2) Small intestine of rat subjected to 90-min ischemia showing mildly shortened,
broadened villi and extensive denudation of the villus epithelium. (A3) Small intestine subjected to 60-min ischemia and 5-min reperfu-
sion showing further shortening and broadening of villi and loss of villus epithelium. (B1). Small intestine of control rat perfused with
nitric oxide. (B2) Small intestine subjected to 90-min ischemia with simultaneous luminal perfusion of nitric oxide donor. (B3) Small
intestine subjected to 60-min ischemia and 5-min reperfusion along with luminal perfusion of nitric oxide donor showing partial short-
ening and broadening of villi and disruption of villus epithelium. Experimental details are described in the text.
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epithelial necrosis (Fig. 2c). However they did show
prominent intercellular edema.
3.3. E¡ect of nitric oxide donor on mitochondrial
function as assessed by MTT reduction
Mitochondrial function can be assessed by the re-
duction of the tetrazolium salt MTT to its formazan,
which gives an index of cell viability and mitochon-
drial function. Our earlier work with ischemia of 30,
60, and 90 min and ischemia followed by 5-min re-
perfusion suggested that, 30-and 60-min ischemia
alone produce reversible change in MTT reduction,
whereas 90-min ischemia alone or 30- or 60-min
ischemia followed by 5-min reperfusion results in
irreversible damage to mitochondria as assessed by
Fig. 2. Electron microscopic appearance of epithelial cells after ischemia and the e¡ect of NO. (a) Epithelial cells of control rat with
normal mitochondria (arrow). (b) Epithelial cells of rat subjected to 90-min ischemia with markedly dilated mitochondria (arrow),
showing decreased matrix density and peripherally situated cristae. (c) Epithelial cells of rat exposed to nitric oxide and 90-min ische-
mia with normal mitochondria (arrow). Experimental details are described in the text.
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MTT reduction [12]. Hence MTT reduction was
assessed with and without succinate using isolated
enterocyte mitochondria from animals subjected to
intestinal ischemia for 90 min, and 60-min ischemia
with 5-min reperfusion in the absence and luminal
presence of nitric oxide donor. As can be seen, com-
pared to control, in 90-min ischemia alone or 60-min
ischemia followed by 5-min reperfusion, the ability of
the mitochondria to reduce MTT is signi¢cantly de-
creased (Fig. 3A), whereas luminal perfusion of rats
with 1 mM nitric oxide donor, sodium nitroprusside,
enhanced the mitochondrial MTT reduction signi¢-
cantly in both ischemia or ischemia followed by re-
perfusion (Fig. 3B). This was also true in the pres-
ence of the respiratory substrate, succinate.
3.4. Mitochondrial respiratory function
Changes in the respiratory control ratio (RCR) are
shown in Fig. 4. Both ischemia and I/R a¡ected mi-
tochondrial respiratory function as compared to con-
trol. Respiratory control ratio markedly decreased
during ischemia in all groups or ischemia followed
reperfusion (Fig. 4A). Administration of nitric oxide
donor signi¢cantly enhanced the recovery of the
RCR (Fig. 4B).
Fig. 3. MTT reduction by isolated enterocyte mitochondria
after graded ischemia and I/R and the e¡ect of nitric oxide. I,
control ; II, 90-min ischemia; and III, 60-min ischemia followed
by 5-min reperfusion. (A) MTT reduction by mitochondria in
the presence and absence of succinate. (B) E¡ect of NO treat-
ment on MTT reduction. Experimental details are described in
the text. Data represent mean þ S.D. of three separate experi-
ments. *P6 0.05 versus that of mitochondria from control.
Fig. 4. Respiratory control ratio (RCR) of isolated enterocyte
mitochondria after graded ischemia and I/R (A) and the e¡ect
of nitric oxide (B). Con, control; I30, I60 and I90, ischemia
alone for 30, 60 and 90 min; I30R and I60R, ischemia of 30
and 60 min followed by 5-min reperfusion. Experimental details
are described in the text. Data represent mean þ S.D. of three
separate experiments. *P6 0.05 versus that of control mito-
chondria.
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3.5. E¡ect of nitric oxide donor on mitochondrial
swelling
A signi¢cant decrease in absorbance at 540 nm
was observed after ischemia in all groups (Fig. 5A),
indicating that the mitochondria have undergone the
permeability transition, whereas this decrease was
not seen in ischemia or I/R with luminal perfusion
of nitric oxide donor. This indicated that the mito-
chondrial permeability transition is prevented by the
presence of nitric oxide (Fig. 5B).
3.6. E¡ect of nitric oxide on mitochondrial lipid
changes after ischemia/reperfusion
Table 1 summarizes the neutral lipid changes after
ischemia or ischemia followed by 5-min reperfusion
as compared to control. No signi¢cant di¡erences
were found in the neutral lipids except free fatty
acids. Ischemia of increasing duration caused a pro-
gressive increase in free fatty acids, with ischemia of
90 min or ischemia followed by 5-min reperfusion
causing signi¢cant increase as compared to control.
Interestingly, when simultaneous luminal perfusion
with nitric oxide donor, SNP showed a complete
prevention of free fatty acid release in either long-
term ischemia (90 min) or ischemia (60 min) with
short-term reperfusion (5 min) (Table 2).
Phospholipid composition was also analyzed fol-
lowing ischemia or ischemia with short-term reperfu-
sion. As can be seen in Table 3, ischemia of all
groups showed a signi¢cant decrease in major phos-
pholipids namely, phosphatidylcholine and phospha-
tidylethanolamine. Similar changes were observed in,
I/R but degradation was much more prominent than
Fig. 5. Swelling of isolated enterocyte mitochondria after
graded ischemia and I/R (A) and the e¡ect of nitric oxide (B).
Swelling was assessed by decrease in absorbance at 540 nm. Ex-
perimental details are described in the text. The abbreviations
used are same as given in Fig. 2. Data represent mean þ S.D. of
three separate experiments. *P6 0.05 versus that of mitochon-
dria from control.
Table 2
Neutral lipid composition of intestinal mitochondria in control, ischemia and I/R in NO-treated animals
Neutral lipids Control I90 I60R
Free fatty acids 114.50 þ 10.50 120.00 þ 8.40a 118.70 þ 7.00a
Cholesterol 84.00 þ 5.00 82.90 þ 4.00 85.70 þ 6.00
Cholesteryl ester 32.70 þ 4.90 30.70 þ 3.10 34.00 þ 2.70
Triglycerides 86.00 þ 8.00 84.70 þ 6.20 88.10 þ 4.90
Diglycerides 52.37 þ 3.00 55.70 þ 4.00 58.70 þ 4.30
Each value (nmol/mg protein) represents mean þ S.D. of three separate estimations. I90, 90-min ischemia alone; I60R, 60-min ischemia
followed by 5-min reperfusion. Lumen was perfused with 1 mM SNP during 15 min prior to and during the active experimental dura-
tion.
aP6 0.05 compared to ischemia and I/R.
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ischemia alone. Simultaneously, progressive increase
in lysophosphatidylcholine was seen in all these
groups. There was no signi¢cant change in lysophos-
phatidylethanolamine in either ischemia or ischemia
followed by reperfusion. These changes in phospho-
lipids were prevented by the luminal perfusion of NO
donor (Table 4). Our earlier work has shown that
intestinal mitochondria have a PLD activity, which
can be stimulated by oxygen free radicals, divalent
metal ions and polyamines [13,38,41]. The increased
PE degradation observed in ischemia and I/R sug-
gests that possibly PE degradation is brought about
by PLD activity. This was further con¢rmed by PA
estimation, which showed a signi¢cant increase in PA
formation in ischemia and I/R (Fig. 6A). This de-
crease in PE and increase in PA formation were com-
pletely prevented by the luminal perfusion of NO
donor (Fig. 6B). There was no change in the level
of other phospholipids namely, phosphatidylserine,
phosphatidylinositol, sphingomyelin, and cardiolipin
(Tables 3 and 4).
4. Discussion
Intestinal I/R results in epithelial cell damage and
is primarily due to generation of oxygen free radicals.
Xanthine oxidase and in¢ltrated phagocytes have
been suggested to be important sources of oxygen
free radicals during I/R injury [2]. Nitric oxide, pro-
duced by the NO synthase enzyme is an important
regulator of intestinal blood £ow and mucosal bar-
rier function [42^44]. NG-nitro-L-arginine methyl es-
Table 3
Phospholipid composition of intestinal mitochondria from control, ischemia and ischemia followed by reperfusion
Phospholipid Control I30 I60 I90 I30R I60R
Phosphatidylcholine 86.67 þ 3.67 81.45 þ 3.20 79.65 þ 2.58 62.29 þ 3.63a 66.90 þ 3.60a 59.25 þ 3.10a
Phosphatidylethanolamine 83.93 þ 3.50 75.94 þ 3.35a 69.00 þ 4.00a 54.70 þ 3.10a 53.17 þ 4.00a 43.30 þ 3.70a
LysoPC 8.85 þ 0.74 9.85 þ 0.50 11.55 þ 1.00 38.70 þ 2.30a 28.60 þ 2.10a 38.23 þ 2.90a
LysoPE 11.26 þ 0.65 12.20 þ 1.40 12.58 þ 1.00 12.96 þ 1.10 11.80 þ 0.80 13.60 þ 1.40
PI and PS 22.46 þ 1.56 21.19 þ 1.60 22.75 þ 1.22 22.12 þ 1.90 22.10 þ 1.90 23.20 þ 2.00
Sphingomyelin 15.35 þ 0.73 15.56 þ 1.68 14.77 þ 1.08 14.71 þ 1.85 15.00 þ 1.20 15.15 þ 1.56
Cardiolipin 25.82 þ 1.88 24.88 þ 2.23 24.98 þ 2.21 23.34 þ 2.59 25.15 þ 1.23 25.20 þ 1.70
Each value (nmol/mg protein) represents mean þ S.D. of three separate estimations. The abbreviations are the same as given in
Table 1.
aP6 0.05 as compared to control mitochondria.
Fig. 6. Phosphatidic acid content of isolated enterocyte mito-
chondria after graded ischemia and I/R (A) and the e¡ect of ni-
tric oxide (B). Experimental details are described in the text.
The abbreviations used are same as given in Fig. 2. Data repre-
sent mean þ S.D. of three separate experiments. *P6 0.05 versus
that of mitochondria from control.
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ter (L-NAME) is an inhibitor of nitric oxide synthesis
and has been used to inhibit the e¡ect of NO. Studies
of ischemia reperfusion in the feline small intestine
have shown that I/R induced mucosal and microvas-
cular permeability increases were dramatically aug-
mented by NAME infusion and this e¡ect was re-
versed by infusion of L-arginine [21]. Other studies
also have indicated a bene¢cial e¡ect of NO in I/R
injury [45,46], whereas there are few reports that in-
dicated an exacerbation of I/R injury upon treatment
with NO [47]. This study has looked into the struc-
tural and functional alterations in enterocyte mito-
chondria during I/R injury and the e¡ect of NO do-
nor, sodium nitroprusside on these alterations. We
used SNP as a NO donor at a concentration of
1 mM, and a £ow rate of 1 ml/min and this would
result in an available NO concentration of 10 nM.
Reaction with oxygen would result in a decrease of
NO concentration over time, and hence, the ¢nal NO
level available to enterocytes would be compatible
with physiological levels [46].
The intestinal villi are extremely susceptible to is-
chemic damage and their necrosis is one of the ear-
liest histological changes that occur during intestinal
ischemia [48]. Our earlier histological studies have
indicated morphological changes in the gut due to
ischemia and reperfusion and the damage was found
to be more severe after reperfusion. These results
suggested that mucosal damage occurs during I/R
and free radicals generated by the in¢ltrated neutro-
phils may play a role in this damaging process [9,49].
Intestinal alkaline phosphatase activity, which is lo-
calized in the villus cells [50], was signi¢cantly de-
creased during I/R [12]. Sisley et al. [51] suggested
that a loss in activity of intestinal alkaline phospha-
tase occurs during reperfusion and this may be a
speci¢c marker for reperfusion injury. In this study,
we have observed that nitric oxide protected the mu-
cosa from the ischemia and ischemia followed by
reperfusion damage. Epithelial detachment and villus
collapse were less severe in the mucosa exposed to
nitric oxide donor than in the mucosa subjected to
I/R. I/R showed focal necrosis in crypt bases that was
not seen in the tissue exposed to nitric oxide donor.
A prominent feature of cell damage caused by oxy-
gen free radicals is structural and functional damage
to mitochondria. It was seen that long duration is-
chemia alone or I/R had a damaging e¡ect on mito-
chondrial function as assessed by MTT reduction
and the respiratory control ratio. We have earlier
shown that short duration of ischemia alone (30 or
60 min) results in reversible damage to mitochondria
as seen by MTT reduction in presence of succinate,
whereas long-duration (90 min) ischemia alone or 30-
or 60-min ischemia followed by 5-min reperfusion
results in irreversible damage [12]. Hence, in this
study, MTT reduction was carried out only for
90-min ischemia alone or 60-min ischemia followed
by 5-min reperfusion and this was done with and
without NO donor. The presence of NO donor com-
pletely reversed the e¡ect of I/R damage as seen by
measurement of respiratory control ratio and mito-
chondrial permeability transition. These parameters,
which are indicative of functional damage to mito-
chondria, are reversed by NO, indicating a bene¢cial
role for this compound in I/R injury.
Functional alterations may be induced by structur-
al changes in the mitochondria and this was checked
by analyzing the lipid composition of the mitochon-
dria that are essential components of the mitochon-
Table 4
Phospholipid composition of intestinal mitochondria in control, ischemia and ischemia followed by reperfusion in NO-treated animals
Phospholipids Control I90 I60R
Phosphatidylcholine 84.94 þ 6.03 81.60 þ 6.44a 82.20 þ 7.00a
Phosphatidylethanolamine 80.78 þ 5.97 79.20 þ 4.56a 79.25 þ 5.06a
LysoPC 8.62 þ 1.00 11.58 þ 1.56a 12.04 þ 1.58a
LysoPE 10.81 þ 0.66 12.19 þ 1.18 12.80 þ 1.62
PI and PS 21.23 þ 1.26 21.52 þ 1.60 21.04 þ 1.95
Sphingomyelin 16.04 þ 1.90 15.01 þ 1.93 15.03 þ 0.76
Cardiolipin 25.23 þ 1.78 23.58 þ 1.19 23.84 þ 2.03
Each value (nmol/mg protein) represents mean þ S.D. of three separate estimations. The abbreviations are same as given in Table 2.
aP6 0.05 as compared to ischemia and I/R.
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drial membrane. During the course of hypoxia, or
ischemic tissue injury, membrane phospholipid
breakdown occurs, leading to the accumulation of
various cytotoxic products. In this study, during is-
chemia or I/R, lipid alterations in the mitochondria
were seen. The prominent alterations include de-
crease in PC and PE and an increase in lysoPC
and free fatty acids. Phospholipids comprise the ma-
jor structural framework of cell membranes and fatty
acids and lysophospholipids once generated can exert
toxic e¡ects [52^54]. These phospholipid changes are
attributed to PLA2-induced membrane damage. Ear-
lier reports have shown that I/R injury is associated
with activation of mucosal PLA2 [55]. Both mem-
brane associated and cytosolic PLA2 have been
shown to be present in the mucosal cells [56]. Sim-
ilarly, calcium-dependent and -independent PLA2
have been reported [57,58]. It has been shown that
the translocation of cytosolic PLA2 to membranes
occurs during O2 deprivation potentially enhancing
their ability to evoke membrane damage [57]. The
increase in free fatty acids and lysophospholipids
was completely prevented by the luminal perfusion
with NO donor.
In addition to PLA2 products, an increase in PA
was seen during I/R injury in the enterocyte mito-
chondria. This PA is generated by the activation of
PLD and we have shown earlier that intestinal mito-
chondria have an active PLD, which can be stimu-
lated by oxygen free radicals or calcium [13,38]. It
was also shown that this PLD speci¢cally utilizes PE
as substrate when stimulated by free radicals or cal-
cium [13,38]. The changes seen in this study clearly
showed that concomitant with the decrease in PE, an
increase in PA was seen, suggesting that the PLD is
likely to be activated by free radicals and/or calcium.
Increase in PA in the mitochondrial membrane may
induce functional alterations in the mitochondria.
PA is known to facilitate calcium transport and in-
crease in PA in mitochondrial membrane alters the
calcium homeostasis. It has been reported that alter-
ation in calcium homeostasis plays an important role
in I/R injury [25]. This alteration in PE and PA levels
was completely prevented by the simultaneous pres-
ence of NO donor in the lumen. This supports our
earlier observation that enterocyte mitochondrial
PLD is activated by oxygen free radicals and calci-
um, and inhibited by NO [24]. There is very little
information on the mitochondrial damage during
I/R injury and this study has clearly shown that con-
comitant with the lipid alterations in the mitochon-
dria, functional alterations are also seen. Both the
structural and functional alteration to intestinal mi-
tochondria brought about during I/R is completely
prevented by NO. Since, in this study, we observed
an increase in PLD activity with 30-min ischemia it is
probable that this is an early event in ischemic dam-
age that is prevented by nitric oxide. To our knowl-
edge, this is the ¢rst report showing mitochondrial
PLD inhibition by nitric oxide under in vivo oxida-
tive stress, namely I/R.
NO may bring about protection to the tissue
through various mechanisms. Superoxide is known
to be generated during I/R, and nitric oxide has the
capacity to inhibit reactive oxygen metabolites, in-
cluding superoxide anion by rapidly reacting with
superoxide and abolishing its biological activity
[45]. Nitric oxide can also suppress xanthine oxidase
activity [59]. The antioxidant action of NO was also
shown in vivo where the antioxidant capacity of plas-
ma was doubled by addition of NO donors [60]. In
our experiments, perfusion with NO did not cause
any damage to mitochondrial structure and function
and hence it is unlikely that peroxynitrite may have a
role in this process. NO is also known to a¡ect the
activity of neutrophil NADPH oxidase which is re-
sponsible for generation of O32 by in¢ltrated neutro-
phils, and NO may increase the blood £ow and hence
o¡er protection.
In conclusion, this study has shown that long du-
ration of ischemia or ischemia followed by reperfu-
sion potentially damages enterocyte mitochondrial
structure and function. The data also strongly sup-
port the contention that nitric oxide plays a protec-
tive role in the intestine during periods of ischemia
and I/R, and its decreased level may exacerbate tissue
injury. This may be brought about by alterations in
mitochondrial lipid composition through altered
PLD activity and this enzyme may have a crucial
role in enterocyte mitochondrial damage during I/R
injury.
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